Abbott Laboratories (ABT) Amortization - Intangibles (2012 - 2026)

Abbott Laboratories has disclosed Amortization - Intangibles across 15 years of filings, most recently posting $658.0 million for Q2 2026.

• In Q2 2026, Amortization - Intangibles rose 56.67% year-over-year to $658.0 million; the TTM figure through Jun 2026 stood at $1.9 billion (up 8.28% YoY), while the FY2025 annual figure was $1.7 billion, down 10.44% from the prior year.
• Amortization - Intangibles came in at $658.0 million for Q2 2026 at Abbott Laboratories, up from $422.0 million in the prior quarter.
• In the past five years, Amortization - Intangibles ranged from a high of $658.0 million in Q2 2026 to a low of $420.0 million in Q1 2025.
• Average Amortization - Intangibles over 5 years is $478.8 million, with a median of $476.5 million recorded in 2023.
• Year-over-year, Amortization - Intangibles declined 11.02% in 2025 and surged 56.67% in 2026.
• Over 5 years, Amortization - Intangibles stood at $496.0 million in 2022, then fell by 3.02% to $481.0 million in 2023, then retreated by 3.33% to $465.0 million in 2024, then retreated by 9.25% to $422.0 million in 2025, then soared by 55.92% to $658.0 million in 2026.
• Per Business Quant data, the three most recent Amortization - Intangibles figures were $658.0 million in Q2 2026, $422.0 million in Q1 2026, and $422.0 million in Q4 2025.